Showing 1 - 1 results of 1 for search 'Mary Erickson', query time: 0.01s Refine Results
  1. 1
    Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INT‐787, a Novel Farnesoid X Receptor Agonist, in Healthy Volunteers: A Phase 1 Trial

    Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INT‐787, a Novel Farnesoid X Receptor Agonist, in Healthy Volunteers: A Phase 1 Trial by Thomas Capozza, Jennifer Burkey, Jeroen Van De Wetering, Reinhold Kerb, Jennifer Callahan, Ludmila Kryzhanovskaya, Mary Erickson

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: